Consultation Documents (5th March 2010-18th March 2010)
NICE are now consulting on the following:
Barrett's oesophagus - ablative therapy: draft guideline consultation - closing date 7th April 2010
Nocturnal enuresis in children (bedwetting): guideline consultation - closing date 6th May 2010
Hypertension (update): scoping workshop, consultation and final scope - closing date 8th April 2010
Social and emotional wellbeing - vulnerable children at home: consultation on the draft scope - closing date 13th April 2010
Social and emotional wellbeing: early education and daycare: consultation on the draft scope - closing date 13th April 2010
Spasticity in Children: draft scope consultation - closing date 9th April 2010
Psoriatic arthritis - etanercept, infliximab & adalimumab (review): appraisal consultation document - closing date 8th April 2010
QOF Indicators in development - closing date 11th April 2010
Upper gastrointestinal bleeding: scope consultation - closing date 16th April 2010
Growth failure (in children) - human growth hormone (HGH) (review): final appraisal determination - closing date 1st April 2010
NICE are now consulting on the following:
Barrett's oesophagus - ablative therapy: draft guideline consultation - closing date 7th April 2010
Nocturnal enuresis in children (bedwetting): guideline consultation - closing date 6th May 2010
Hypertension (update): scoping workshop, consultation and final scope - closing date 8th April 2010
Social and emotional wellbeing - vulnerable children at home: consultation on the draft scope - closing date 13th April 2010
Social and emotional wellbeing: early education and daycare: consultation on the draft scope - closing date 13th April 2010
Spasticity in Children: draft scope consultation - closing date 9th April 2010
Psoriatic arthritis - etanercept, infliximab & adalimumab (review): appraisal consultation document - closing date 8th April 2010
QOF Indicators in development - closing date 11th April 2010
Upper gastrointestinal bleeding: scope consultation - closing date 16th April 2010
Growth failure (in children) - human growth hormone (HGH) (review): final appraisal determination - closing date 1st April 2010
Latest Implementation Tools (11th March 2010)
Tools to aid implementation of latest guidance:
Tools to aid implementation of latest guidance:
CG93 Donor Breast Milk Banks: audit support, costing tool and slide set
TA186 Rheumatoid arthritis - certolizumab pegol: audit support and costing tool
TA185 Soft tissue sarcoma - trabectedin: audit support and costing tool
PH23 School-based interventions to prevent smoking: slide set and costing tool
IPG331 Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis (replacing of IPG116): audit support
IPG332 Surgical correction of hallux valgus using minimal access: audit support
Therapeutic endoscopic division of epidural adhesions (review of IPG88): audit support
No comments:
Post a Comment